QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2020     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Development of Taccalonolide AJ-Hydroxypropyl-beta-Cyclodextrin Inclusion Complexes for Treatment of Clear Cell Renal-Cell Carcinoma 期刊论文 MOLECULES, 2020, 卷号: 25, 期号: 23, 页码: 14 作者:  Han, Jing;  Zhang, Siwang;  Niu, Junxin;  Zhang, Chunli;  Dai, Weichen 收藏  |  浏览/下载：28/0  |  提交时间：2021/05/24 taccalonolide AJ  microtubule stabilizer  hydroxypropyl-β  -cyclodextrin  inclusion complex  clear-cell renal-cell carcinoma   Multiparametric MRI Radiomic Model for Preoperative Predicting WHO/ISUP Nuclear Grade of Clear Cell Renal Cell Carcinoma 期刊论文 JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 页码: 10 作者:  Li, Qiong;  Liu, Yu-jia;  Dong, Di;  Bai, Xu;  Huang, Qing-bo 收藏  |  浏览/下载：29/0  |  提交时间：2020/06/22 renal cell carcinoma  nuclear grade  radiomic  magnetic resonance imaging   Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma 期刊论文 ANNALS OF SURGICAL ONCOLOGY, 2020, 卷号: 27, 期号: 10, 页码: 4057–4065 作者:  Zhou, Hongyu;  Mao, Haixia;  Dong, Di;  Fang, Mengjie;  Gu, Dongsheng 收藏  |  浏览/下载：55/0  |  提交时间：2020/06/22 Clear Cell Renal Cell Carcinoma   Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent 期刊论文 ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10 作者:  Jiang, Zongru;  Wang, Li;  Liu, Xuesong;  Chen, Cheng;  Wang, Beilei 收藏  |  浏览/下载：25/0  |  提交时间：2020/11/26 Cancer  VEGFR2 kinase  Kinase inhibitor  Angiogenesis  Inhibitor selectivity   Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis 期刊论文 AGING-US, 2020, 卷号: 12, 期号: 21, 页码: 21854-21873 作者:  Wang, Yutao;  Yan, Kexin;  Lin, Jiaxing;  Wang, Jianfeng;  Zheng, Zhenhua 收藏  |  浏览/下载：38/0  |  提交时间：2020/12/05 papillary renal cell carcinoma (PRCC)  robust risk model  weighted gene co-expression network analysis (WGCNA)  immune infiltration  tumor mutation burden (TMB)